These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 37505691)
1. The Growing Importance of Three-Dimensional Models and Microphysiological Systems in the Assessment of Mycotoxin Toxicity. Zingales V; Esposito MR; Torriero N; Taroncher M; Cimetta E; Ruiz MJ Toxins (Basel); 2023 Jun; 15(7):. PubMed ID: 37505691 [TBL] [Abstract][Full Text] [Related]
2. Three-dimensional (3D) cell culture studies: a review of the field of toxicology. İpek S; Üstündağ A; Can Eke B Drug Chem Toxicol; 2023 May; 46(3):523-533. PubMed ID: 35450503 [TBL] [Abstract][Full Text] [Related]
3. In vitro 3D skin culture and its sustainability in toxicology: a narrative review. Masri S; Fauzi MB; Rajab NF; Lee WH; Zainal Abidin DA; Siew EL Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):476-499. PubMed ID: 39359233 [TBL] [Abstract][Full Text] [Related]
4. Review: 3D cell models for organ-on-a-chip applications. Żuchowska A; Baranowska P; Flont M; Brzózka Z; Jastrzębska E Anal Chim Acta; 2024 May; 1301():342413. PubMed ID: 38553129 [TBL] [Abstract][Full Text] [Related]
5. Three dimensional spheroid cell culture for nanoparticle safety testing. Sambale F; Lavrentieva A; Stahl F; Blume C; Stiesch M; Kasper C; Bahnemann D; Scheper T J Biotechnol; 2015 Jul; 205():120-9. PubMed ID: 25595712 [TBL] [Abstract][Full Text] [Related]
6. From animal testing to Reyes DR; Esch MB; Ewart L; Nasiri R; Herland A; Sung K; Piergiovanni M; Lucchesi C; Shoemaker JT; Vukasinovic J; Nakae H; Hickman J; Pant K; Taylor A; Heinz N; Ashammakhi N Lab Chip; 2024 Feb; 24(5):1076-1087. PubMed ID: 38372151 [TBL] [Abstract][Full Text] [Related]
7. Advanced biomedical applications based on emerging 3D cell culturing platforms. Wang A; Madden LA; Paunov VN J Mater Chem B; 2020 Dec; 8(46):10487-10501. PubMed ID: 33136103 [TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional Liver Culture Systems to Maintain Primary Hepatic Properties for Toxicological Analysis In Vitro. Kammerer S Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638555 [TBL] [Abstract][Full Text] [Related]
9. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development. Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075 [TBL] [Abstract][Full Text] [Related]
10. Fish hepatocyte spheroids - A powerful (though underexplored) alternative in vitro model to study hepatotoxicity. Alves RF; Rocha E; Madureira TV Comp Biochem Physiol C Toxicol Pharmacol; 2022 Dec; 262():109470. PubMed ID: 36122680 [TBL] [Abstract][Full Text] [Related]
11. Recent Progress in Hepatocyte Culture Models and Their Application to the Assessment of Drug Metabolism, Transport, and Toxicity in Drug Discovery: The Value of Tissue Engineering for the Successful Development of a Microphysiological System. Tetsuka K; Ohbuchi M; Tabata K J Pharm Sci; 2017 Sep; 106(9):2302-2311. PubMed ID: 28533121 [TBL] [Abstract][Full Text] [Related]
12. Modeling immunity in microphysiological systems. Kwee BJ; Li X; Nguyen XX; Campagna C; Lam J; Sung KE Exp Biol Med (Maywood); 2023 Nov; 248(22):2001-2019. PubMed ID: 38166397 [TBL] [Abstract][Full Text] [Related]
13. Advances in the formation, use and understanding of multi-cellular spheroids. Achilli TM; Meyer J; Morgan JR Expert Opin Biol Ther; 2012 Oct; 12(10):1347-60. PubMed ID: 22784238 [TBL] [Abstract][Full Text] [Related]
14. Development of an in vitro neuroblastoma 3D model and its application for sterigmatocystin-induced cytotoxicity testing. Zingales V; Torriero N; Zanella L; Fernández-Franzón M; Ruiz MJ; Esposito MR; Cimetta E Food Chem Toxicol; 2021 Nov; 157():112605. PubMed ID: 34634377 [TBL] [Abstract][Full Text] [Related]
15. Navigating Through Cell-Based In vitro Models Available for Prediction of Intestinal Permeability and Metabolism: Are We Ready for 3D? Franco YL; Da Silva L; Cristofoletti R AAPS J; 2021 Nov; 24(1):2. PubMed ID: 34811603 [TBL] [Abstract][Full Text] [Related]
16. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems. Hughes DJ; Kostrzewski T; Sceats EL Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617 [TBL] [Abstract][Full Text] [Related]
18. Microphysiological systems to study colorectal cancer: state-of-the-art. Ramos P; Carvalho MR; Chen W; Yan LP; Zhang CH; He YL; Reis RL; Oliveira JM Biofabrication; 2023 Apr; 15(3):. PubMed ID: 36888998 [TBL] [Abstract][Full Text] [Related]
19. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation. Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907 [TBL] [Abstract][Full Text] [Related]
20. Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity. Tutty MA; Vella G; Prina-Mello A Drug Deliv Transl Res; 2022 Sep; 12(9):2157-2177. PubMed ID: 35763196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]